SBIR/STTR Research Award
Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion
Award amount
$149,979Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- CYTOSORBENTS MEDICAL INC
- Proposal award date
- 2016-04-19
- Contract end date
- 2016-11-18
- UEI
- LSF2KFUSY4K7
- Solicitation number
- 2015.0
- Topic code
- DHP15B-001
Research abstract
The ready availability of universal donor plasma to rapidly treat massively bleeding hospital trauma patients and warfighters with combat casualties is a key element of current recommendations for trauma resuscitation, yet universal AB donor plasma is rel
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Oral Sorbent Therapy for the Prevention and Treatment of Traveler’s Diarrhea
- Novel Sorbent Technology for the Rapid Treatment of Acute Joint Injury and Inflammation
- Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability
- Investigation of a potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine
- Development of an Effective Adsorber to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion
- Universal Plasma Generator for Selective Removal of Anti-A and Anti-B Antibodies from Donor Plasma
- Universal Plasma Generator for Selective Removal of Anti-A and Anti-B Antibodies from Donor Plasma
Research funding history
16 SBIR/STTR records share this UEI (2012–2023). Reported award amounts total $11,830,667. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services